SIGLEC1 and viral infectious disease: Given that Sialoadhesin/Siglec-1 appears to be involved in retroviral infection in both mouse and human (103), one may expect that it should evolve rapidly to avoid viral infections; however, Sialoadhesin/Siglec-1 does not appear to be evolving rapidly (Table 1).